PTUPB, a COX2 inhibitor and soluble epoxide hydrolase, can arrest the production of cytokines and lipids, normally releasing by TAMs after chemotherapy, and inhibit ovarian cancer cells’ growth induced by tumor fragments [139]. Here, PTGS2 is linked to neoplasm.